SUBMIT YOUR RESEARCH
Saudi Journal of Medical and Pharmaceutical Sciences (SJMPS)
Volume-10 | Issue-12 | 990-994
Original Research Article
Comparison of Visual Outcome and Optical Quality Monofocal vs Monofocal Plus Intraocular Lens
Prof. Dr. Md. Sanwar Hossain, Dr. Tasnim Khanom, Dr. Md. Arifuzzaman, Dr. Mohammad Mazaharul Islam
Published : Dec. 30, 2024
DOI : DOI: https://doi.org/10.36348/sjmps.2024.v10i12.017
Abstract
Background: Traditional mono-focal intraocular lenses (IOLs) have been commonly used in cataract surgery but have limited intermediate vision. These lenses are designed to achieve improved visual outcomes and optical quality without the drawbacks associated with multifocal lenses. The present study compares visual outcomes, optical quality, and patient satisfaction for Monofocal versus Monofocal-Plus IOLs. Methods: This postoperative observational study was carried out at Department of Ophthalmology, Dr. Sirajul Islam Medical College and Hospital and Bangladesh Eye Hospital, Dhaka, Bangladesh, from July 2022 to June 2023, including 40 cataract surgery patients. Patients were divided in Monofocal IOL (n=20) & Monofocal-Plus IOL (n=20) groups. Preoperative 1-month and 3-month follow-up assessments of visual acuity (LogMAR), contrast sensitivity (logCS), higher-order aberrations (HOA), and patient satisfaction scores were performed. SPSS version 26 was used to analyze data, with a p<0.05 significance level. Results: Uncorrected visual acuity was significantly better 3 months post-op with mono-focal-plus IOL at 3 months (p=0.008), photopic contrast sensitivity (p=0.04), and spherical aberration (p=0.00). There was a trend toward improvement in best-corrected visual acuity (p=0.08). Monofocal-Plus IOL patients reported significantly lower glare (p=0.01) and halos (p=0.01) and better night vision quality scores (p=0.005). The requirement for more spectacles was less in the Monofocal-Plus group (15.0% vs. 35.5%), but not significant (p=0.14). Conclusion: Compared to Monofocal IOLs, Monofocal-Plus IOLs provide better visual performance, optical quality, and higher patient satisfaction. These findings support their adoption as an IOL of choice in cataract surgery.
Scholars Middle East Publishers
Browse Journals
Payments
Publication Ethics
SUBMIT ARTICLE
Browse Journals
Payments
Publication Ethics
SUBMIT ARTICLE
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
© Copyright Scholars Middle East Publisher. All Rights Reserved.